[Erycutan in percutaneous therapy of respiratory tract diseases in children].
D006801:Humans; D009525:Niacin / Q000627:therapeutic use*; D009539:Nicotinic Acids; D012137:Respiratory System; D012140:Respiratory Tract Diseases; D013729:Terpenes / Q000627:therapeutic use*
D009539:Nicotinic Acids; D013729:Terpenes; D009525:Niacin
NICOTINIC ACID/therapeutic use; RESPIRATORY TRACT/diseases; TERPENES/therapeutic use
Erycutan zur perkutanen Therapie kindlicher Atemwegserkrankungen.